These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11253488)
1. [Long-term safety of using tiagabine in epilepsy]. Kozik A Neurol Neurochir Pol; 2000; 34 Suppl 7():17-22; discussion 22-3. PubMed ID: 11253488 [TBL] [Abstract][Full Text] [Related]
2. Long-term safety of tiagabine. Kälviäinen R Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323 [TBL] [Abstract][Full Text] [Related]
3. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Ettinger AB; Bernal OG; Andriola MR; Bagchi S; Flores P; Just C; Pitocco C; Rooney T; Tuominen J; Devinsky O Epilepsia; 1999 Aug; 40(8):1159-62. PubMed ID: 10448832 [TBL] [Abstract][Full Text] [Related]
4. Status epilepticus and tiagabine therapy revisited. Koepp MJ; Edwards M; Collins J; Farrel F; Smith S Epilepsia; 2005 Oct; 46(10):1625-32. PubMed ID: 16190934 [TBL] [Abstract][Full Text] [Related]
5. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Shinnar S; Berg AT; Treiman DM; Hauser WA; Hesdorffer DC; Sackellares JC; Leppik I; Sillanpaa M; Sommerville KW Epilepsia; 2001 Mar; 42(3):372-9. PubMed ID: 11442155 [TBL] [Abstract][Full Text] [Related]
7. Tiagabine (gabitril) experience in children. Pellock JM Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324 [TBL] [Abstract][Full Text] [Related]
8. Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy. de Borchgrave V; Lienard F; Willemart T; van Rijckevorsel K Epilepsy Behav; 2003 Jun; 4(3):326-37. PubMed ID: 12791336 [TBL] [Abstract][Full Text] [Related]
9. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Mangano S; Cusumano L; Fontana A Brain Dev; 2003 Oct; 25(7):518-21. PubMed ID: 13129597 [TBL] [Abstract][Full Text] [Related]
11. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy]. Kozik A; Krause M Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750 [TBL] [Abstract][Full Text] [Related]
16. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Eckardt KM; Steinhoff BJ Epilepsia; 1998 Jun; 39(6):671-4. PubMed ID: 9637612 [TBL] [Abstract][Full Text] [Related]
17. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy. Kälviäinen R J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435 [TBL] [Abstract][Full Text] [Related]
18. Various Aspects of Tiagabine Effectiveness as Add-on Therapy in Patients with Refractory Epilepsy. Viteva E; Zahariev Z Folia Med (Plovdiv); 2020 Mar; 62(1):59-64. PubMed ID: 32337898 [TBL] [Abstract][Full Text] [Related]
19. Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina. Sills GJ; Patsalos PN; Butler E; Forrest G; Ratnaraj N; Brodie MJ Neurology; 2001 Jul; 57(2):196-200. PubMed ID: 11468302 [TBL] [Abstract][Full Text] [Related]
20. Safety of long-term treatment with tiagabine. Fakhoury T; Uthman B; Abou-Khalil B Seizure; 2000 Sep; 9(6):431-5. PubMed ID: 10986002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]